Modelling comparative efficacy of drugs with different survival profiles: Ipilimumab, vemurafenib and dacarbazine in advanced melanoma

Authors:

Lee D, Porter J, Hertel N, Hatswell AJ and Briggs A.

Publication Type:

Journal Article

Publication Name:

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Citation:

Lee D, Porter J, Hertel N, Hatswell AJ and Briggs A. Modelling comparative efficacy of drugs with different survival profiles: Ipilimumab, vemurafenib and dacarbazine in advanced melanoma. Biodrugs. 2016;30(4):307-19.

 


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies